Cannabis use prevalence before and early after partial legalisation in Germany
Abstract
ABSTRACT Background and Aims On April 1st, 2024, Germany implemented the Act on the Handling of Cannabis for Non-Medical Use (KCanG), allowing adults to cultivate and possess recreational cannabis. We assessed whether this policy shift was associated with a change in the prevalence of cannabis use in the general population and in daily or almost daily cannabis use. Design A series of 21 repeated cross-sectional surveys conducted between April/May 2022 and October/November 2025 (covering the period approximately two years before and one and a half years after the KCanG). Setting Population of Germany. Participants A total of 32,991 people aged 14-64 years, including 2,092 (6.3%) people who used cannabis in the past 12 months. Measurements Past 12-month cannabis use (at least once). In past 12-month users: daily or almost daily use. To test a potential change in prevalence following the KCanG, we used piecewise binomial logistic regression models using the exact date of each wave as the predictor variable, allowing for a change in the slope at the first full wave after implementation of the KCanG in April 2024, with a random effect for wave. We conducted this analysis for the total sample as well as stratified by gender (male vs. female), age (14-24 vs. 25-64 years), and for daily or almost daily cannabis use in the subgroup of people who used cannabis in the past 12 months. Sensitivity analyses used alternate intervention dates (in-time placebo tests). Findings The prevalence of cannabis use and the share of (almost) daily users among 12-month users remained largely stable before and after the law reform. None of the slope coefficients before the introduction of the KCanG were statistically significant (all p ≥ .08), and none of the coefficients for the change in the slope were statistically significant (all p ≥ .31). Results of sensitivity analyses confirmed the stable trends for both outcomes. Conclusions The legislation of cannabis introduced in Germany in April 2024 was not associated with a change in trends of 12-month cannabis use prevalence early (1.5 years) after implementation, and also not with a change in the proportion of heavy users among past-12-month users. We recommend continued close monitoring of trends using multiple data sources and over a longer post-implementation period, as the effects of the legislation may not have fully unfolded yet.
Fields of Study & Subjects
Cannabis and Cannabinoid Research
Substance Abuse Treatment and Outcomes
Psychedelics and Drug Studies
Publication details
- Journal / source
- medRxiv
- Publisher
- openRxiv
- Publication date
- 19 March 2026
- Document type
- Preprint